These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25238391)

  • 1. Parkin (PARK 2) mutations are rare in Czech patients with early-onset Parkinson's disease.
    Fiala O; Zahorakova D; Pospisilova L; Kucerova J; Matejckova M; Martasek P; Roth J; Ruzicka E
    PLoS One; 2014; 9(9):e107585. PubMed ID: 25238391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkin mutations and phenotypic features in Czech patients with early-onset Parkinson's disease.
    Fiala O; Pospisilova L; Prochazkova J; Matejckova M; Martasek P; Novakova L; Roth J; Ruzicka E
    Neuro Endocrinol Lett; 2010; 31(2):187-92. PubMed ID: 20424582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis of Parkin in early onset Parkinson's disease (PD): Novel intron 9 g > a single nucleotide polymorphism and risk of Taiwanese PD.
    Wu YR; Wu CH; Chao CY; Kuan CC; Zhang WL; Wang CK; Chang CY; Chang YC; Lee-Chen GJ; Chen CM
    Am J Med Genet B Neuropsychiatr Genet; 2010 Jan; 153B(1):229-34. PubMed ID: 19475582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkin and PINK1 mutations in early-onset Parkinson's disease: comprehensive screening in publicly available cases and control.
    Brooks J; Ding J; Simon-Sanchez J; Paisan-Ruiz C; Singleton AB; Scholz SW
    J Med Genet; 2009 Jun; 46(6):375-81. PubMed ID: 19351622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PARK2 variability in Polish Parkinson's disease patients--interaction with mitochondrial haplogroups.
    Gaweda-Walerych K; Safranow K; Jasinska-Myga B; Bialecka M; Klodowska-Duda G; Rudzinska M; Czyzewski K; Cobb SA; Slawek J; Styczynska M; Opala G; Drozdzik M; Nishioka K; Farrer MJ; Ross OA; Wszolek ZK; Barcikowska M; Zekanowski C
    Parkinsonism Relat Disord; 2012 Jun; 18(5):520-4. PubMed ID: 22361577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of the parkin gene in South African patients diagnosed with Parkinson's disease.
    Bardien S; Keyser R; Yako Y; Lombard D; Carr J
    Parkinsonism Relat Disord; 2009 Feb; 15(2):116-21. PubMed ID: 18514563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.
    Abbas N; Lücking CB; Ricard S; Dürr A; Bonifati V; De Michele G; Bouley S; Vaughan JR; Gasser T; Marconi R; Broussolle E; Brefel-Courbon C; Harhangi BS; Oostra BA; Fabrizio E; Böhme GA; Pradier L; Wood NW; Filla A; Meco G; Denefle P; Agid Y; Brice A
    Hum Mol Genet; 1999 Apr; 8(4):567-74. PubMed ID: 10072423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of parkin gene mutations and variations in idiopathic Parkinson's disease.
    Sinha R; Racette B; Perlmutter JS; Parsian A
    Parkinsonism Relat Disord; 2005 Sep; 11(6):341-7. PubMed ID: 16019250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. parkin mutation analysis in clinic patients with early-onset Parkinson [corrected] disease.
    Poorkaj P; Nutt JG; James D; Gancher S; Bird TD; Steinbart E; Schellenberg GD; Payami H
    Am J Med Genet A; 2004 Aug; 129A(1):44-50. PubMed ID: 15266615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Point mutation in the parkin gene on patients with Parkinson's disease.
    Wang T; Liang Z; Sun S; Cao X; Peng H; Cao F; Liu H; Tong ET
    J Huazhong Univ Sci Technolog Med Sci; 2003; 23(2):145-7. PubMed ID: 12973932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkin analysis in early onset Parkinson's disease.
    Sironi F; Primignani P; Zini M; Tunesi S; Ruffmann C; Ricca S; Brambilla T; Antonini A; Tesei S; Canesi M; Zecchinelli A; Mariani C; Meucci N; Sacilotto G; Cilia R; Isaias IU; Garavaglia B; Ghezzi D; Travi M; Decarli A; Coviello DA; Pezzoli G; Goldwurm S
    Parkinsonism Relat Disord; 2008; 14(4):326-33. PubMed ID: 18519021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel parkin mutations detected in patients with early-onset Parkinson's disease.
    Bertoli-Avella AM; Giroud-Benitez JL; Akyol A; Barbosa E; Schaap O; van der Linde HC; Martignoni E; Lopiano L; Lamberti P; Fincati E; Antonini A; Stocchi F; Montagna P; Squitieri F; Marini P; Abbruzzese G; Fabbrini G; Marconi R; Dalla Libera A; Trianni G; Guidi M; De Gaetano A; Boff Maegawa G; De Leo A; Gallai V; de Rosa G; Vanacore N; Meco G; van Duijn CM; Oostra BA; Heutink P; Bonifati V;
    Mov Disord; 2005 Apr; 20(4):424-431. PubMed ID: 15584030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between early-onset Parkinson's disease and mutations in the parkin gene.
    Lücking CB; Dürr A; Bonifati V; Vaughan J; De Michele G; Gasser T; Harhangi BS; Meco G; Denèfle P; Wood NW; Agid Y; Brice A; ;
    N Engl J Med; 2000 May; 342(21):1560-7. PubMed ID: 10824074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exon dosage variations in Brazilian patients with Parkinson's disease: analysis of SNCA, PARKIN, PINK1 and DJ-1 genes.
    Moura KC; Junior MC; de Rosso AL; Nicaretta DH; Pereira JS; José Silva D; Santos-Rebouças CB; Pimentel MM
    Dis Markers; 2012; 32(3):173-8. PubMed ID: 22377733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Exon Dosage Using Multiplex Ligation-Dependent Probe Amplification in Chinese Patients with Early-Onset Parkinson's Disease.
    Lin Y; Zeng YF; Cai NQ; Lin XZ; Wang N; He J
    Eur Neurol; 2019; 81(5-6):246-253. PubMed ID: 31618739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case-control study of the parkin gene in early-onset Parkinson disease.
    Clark LN; Afridi S; Karlins E; Wang Y; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Arch Neurol; 2006 Apr; 63(4):548-52. PubMed ID: 16606767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients.
    Kay DM; Moran D; Moses L; Poorkaj P; Zabetian CP; Nutt J; Factor SA; Yu CE; Montimurro JS; Keefe RG; Schellenberg GD; Payami H
    Ann Neurol; 2007 Jan; 61(1):47-54. PubMed ID: 17187375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation screening and association analysis of the parkin gene in Parkinson's disease patients from South-West China.
    Peng R; Gou Y; Yuan Q; Li T; Latsoudis H; Yuan G; Luo D; Liu X; Collier DA
    Eur Neurol; 2003; 49(2):85-9. PubMed ID: 12584415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkin variants in North American Parkinson's disease: cases and controls.
    Lincoln SJ; Maraganore DM; Lesnick TG; Bounds R; de Andrade M; Bower JH; Hardy JA; Farrer MJ
    Mov Disord; 2003 Nov; 18(11):1306-11. PubMed ID: 14639672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A new point mutation on exon 2 of parkin gene in Parkinson's disease].
    Xu Y; Liu Z; Wang Y; Tao E; Chen G; Chen B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Oct; 19(5):409-11. PubMed ID: 12362318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.